These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34360948)

  • 1. The Development of Molecular Biology of Osteoporosis.
    Gao Y; Patil S; Jia J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats.
    Hsiao CY; Chen TH; Chu TH; Ting YN; Tsai PJ; Shyu JF
    Front Endocrinol (Lausanne); 2020; 11():613. PubMed ID: 33013696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment.
    Kołodziejska B; Stępień N; Kolmas J
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions.
    Chen LR; Ko NY; Chen KH
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapeutic targets for osteoporosis treatment.
    Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
    Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.
    Zhao X; Patil S; Xu F; Lin X; Qian A
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.
    Noh JY; Yang Y; Jung H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.
    Wang JW; Yeh CB; Chou SJ; Lu KC; Chu TH; Chen WY; Chien JL; Yen MH; Chen TH; Shyu JF
    J Bone Miner Metab; 2018 Sep; 36(5):508-518. PubMed ID: 28983668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.
    Saponaro F; Ferrisi R; Gado F; Polini B; Saba A; Manera C; Chiellini G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy].
    Kryśkiewicz E; Lorenc RS
    Endokrynol Pol; 2009; 60(2):134-44. PubMed ID: 19396757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Cellular mechanism and etiology of osteoporosis].
    Koga T; Takayanagi H
    Clin Calcium; 2015 Sep; 25(9):1293-300. PubMed ID: 26320528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
    Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future developments in osteoporosis therapy.
    Ng KW
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):371-84. PubMed ID: 19857200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats.
    Hasegawa T; Yamamoto T; Sakai S; Miyamoto Y; Hongo H; Qiu Z; Abe M; Takeda S; Oda K; de Freitas PHL; Li M; Endo K; Amizuka N
    J Histochem Cytochem; 2019 Mar; 67(3):169-184. PubMed ID: 30311820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development.
    Li H; Xiao Z; Quarles LD; Li W
    Curr Med Chem; 2021; 28(8):1489-1507. PubMed ID: 32223730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
    Thaler R; Maurizi A; Roschger P; Sturmlechner I; Khani F; Spitzer S; Rumpler M; Zwerina J; Karlic H; Dudakovic A; Klaushofer K; Teti A; Rucci N; Varga F; van Wijnen AJ
    J Biol Chem; 2016 Mar; 291(13):6754-71. PubMed ID: 26757819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone histomorphometry;A role of evaluation for bone quality and mechanical strength].
    Yamamoto N; Takahashi H; Shimakura T
    Clin Calcium; 2016 Jan; 26(1):9-15. PubMed ID: 26728526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium-sensing receptor in bone metabolism: from bench to bedside and back.
    Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML
    Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY
    Osteoporos Int; 2018 Jul; 29(7):1505-1510. PubMed ID: 29869039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.